The DHA and Mediclinic Middle East have signed an agreement which will see Mediclinic operate the DHA’s Al Barsha Dialysis Centre from mid-May. The aim of the partnership is to provide patients with the highest quality of specialised patient-centred care.
The contract was signed on 28 April 2021 at the DHA Headquarters by Awadh Al Ketbi, Director-General of the Dubai Health Authority and David Hadley, CEO, Mediclinic Middle East in presence of a number of high-ranking officials from both sides.
Al Ketbi said that the private health sector is the DHA’s strategic partner. It plays a vital role in the development of the health sector and in achieving Dubai's goals and aspirations of providing the highest quality of accessible and specialised internationally recognised standards of care.
He added that collaboration and exchange of expertise are key factors in the growth and development of the sector.
The specialised centre was built with a generous donation from the sons of the late Abdul Salam Rafiea. The centre has 60 rooms to serve the needs of patients suffering from kidney failure who require regular dialysis. The centre will also provide preventative services in the field of nephrology.
